Rapid health technology assessment of immunisation against respiratory syncytial virus (RSV) in Ireland

Health Information and Quality Authority
Record ID 32018013195
English
Authors' objectives: Respiratory syncytial virus (RSV) is a virus that infects the lungs and upper airways. This virus spreads every winter, with the RSV season in Ireland typically running from October to March. In healthy individuals, infection with RSV can usually be managed without needing to see a doctor. However, RSV can cause more severe infections in some people which may lead to them being hospitalised. Groups vulnerable to serious complications include infants, young children and older adults. At the request of the Department of Health, the Health Information and Quality Authority (HIQA) agreed to undertake a rapid health technology assessment (HTA) of alternative infant and adult immunisation strategies against RSV in Ireland.
Details
Project Status: Completed
Year Published: 2024
Requestor: Department of Health, Ireland
English language abstract: An English language summary is available
Publication Type: Mini HTA
Country: Ireland
MeSH Terms
  • Respiratory Syncytial Virus, Human
  • Respiratory Syncytial Virus Vaccines
  • Respiratory Syncytial Virus Infections
  • Vaccination
  • Infant
  • Adult
  • Aged
Keywords
  • RSV
  • Immunisation
Contact
Organisation Name: Health Information and Quality Authority (HIQA)
Contact Address: Health Information and Quality Authority, George's Court, George's Lane,Smithfield, Dublin 7. PH : + 353 (01) 814 7464
Contact Name: info@hiqa.ie
Contact Email: info@hiqa.ie
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.